Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Non-Current Assets (2016 - 2025)

Apyx Medical's Other Non-Current Assets history spans 16 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 5.29% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 5.29%, while the annual FY2025 figure was $1.8 million, 5.29% up from the prior year.
  • Other Non-Current Assets reached $1.8 million in Q4 2025 per APYX's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q2 2023 to a low of $860000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $1.5 million, with a median of $1.7 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 107.68% in 2021, then fell 6.39% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.1 million in 2021, then grew by 9.64% to $1.2 million in 2022, then surged by 42.32% to $1.7 million in 2023, then dropped by 3.93% to $1.7 million in 2024, then increased by 5.29% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Other Non-Current Assets are $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.7 million (Q2 2025).